GlassScriptPhysician profile
Catherine S Roberts
NPI 1407886278
$715.77
in general payments reported to CMS, 2019-2025
14 companies · $115 in 2025
The $115 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $277 · 2020: $162 · 2024: $162 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $277.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $277.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $205.72 | 2019-2025 | Airsupra, Farxiga |
| Pfizer INC. | $118.14 | 2019-2020 | |
| Novo Nordisk INC | $114.38 | 2019-2025 | Wegovy |
| Amgen INC. | $54.34 | 2019-2025 | Otezla, Repatha |
| Abbvie INC. | $53.54 | 2019-2024 | |
| Lilly USA, LLC | $33.31 | 2020-2025 | Zepbound |
| Exact Sciences Corporation | $32.78 | 2024-2025 | Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $20.04 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.16 | 2019 | |
| Amarin Pharma, INC. | $15.52 | 2020 | |
| Allergan, INC. | $14.27 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.24 | 2019 | |
| Merck Sharp & Dohme LLC | $12.38 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $11.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Roberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.